Henan Lingrui Pharmaceutical Co Ltd
SSE:600285

Watchlist Manager
Henan Lingrui Pharmaceutical Co Ltd Logo
Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
Watchlist
Price: 22.1 CNY -1.69% Market Closed
Market Cap: 12.5B CNY
Have any thoughts about
Henan Lingrui Pharmaceutical Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Henan Lingrui Pharmaceutical Co Ltd

Current Assets 2.1B
Cash & Short-Term Investments 907.7m
Receivables 721.3m
Other Current Assets 470.6m
Non-Current Assets 2.6B
Long-Term Investments 1.5B
PP&E 654.5m
Intangibles 226.4m
Other Non-Current Assets 214.6m
Current Liabilities 1.9B
Accounts Payable 91.2m
Accrued Liabilities 1.3B
Short-Term Debt 96.1m
Other Current Liabilities 495.2m
Non-Current Liabilities 71.7m
Long-Term Debt 6.8m
Other Non-Current Liabilities 64.9m

Balance Sheet
Henan Lingrui Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
371
415
378
340
639
741
0
801
1 179
1 490
Cash
0
0
0
0
1
0
0
801
1 179
1 490
Cash Equivalents
370
415
378
339
639
741
0
0
0
0
Short-Term Investments
19
20
13
10
9
28
57
421
276
96
Total Receivables
159
200
344
579
569
663
717
441
533
518
Accounts Receivables
9
29
30
218
187
173
146
173
196
258
Other Receivables
151
171
314
361
382
491
571
268
337
260
Inventory
223
298
484
365
324
287
331
428
486
467
Other Current Assets
49
31
344
324
54
36
811
40
34
27
Total Current Assets
821
964
1 563
1 617
1 595
1 754
1 917
2 131
2 508
2 599
PP&E Net
491
608
783
851
819
809
772
787
745
678
PP&E Gross
491
608
783
851
819
809
772
787
745
678
Accumulated Depreciation
140
167
209
220
273
326
403
462
525
584
Intangible Assets
167
182
183
319
310
303
283
286
242
230
Goodwill
8
8
1
1
1
1
0
0
0
0
Long-Term Investments
954
999
367
413
278
334
350
456
677
1 069
Other Long-Term Assets
33
73
86
106
108
116
137
133
172
196
Other Assets
8
8
1
1
1
1
0
0
0
0
Total Assets
2 475
N/A
2 833
+14%
2 982
+5%
3 308
+11%
3 110
-6%
3 316
+7%
3 458
+4%
3 793
+10%
4 344
+15%
4 772
+10%
Liabilities
Accounts Payable
55
59
62
85
58
68
79
78
68
57
Accrued Liabilities
56
69
89
96
100
108
538
611
938
1 124
Short-Term Debt
439
390
205
285
280
281
166
296
182
233
Current Portion of Long-Term Debt
25
22
0
0
0
0
0
2
1
1
Other Current Liabilities
185
348
402
543
504
557
284
452
523
484
Total Current Liabilities
759
888
757
1 009
943
1 014
1 066
1 438
1 712
1 900
Long-Term Debt
0
40
20
0
0
0
0
8
6
7
Deferred Income Tax
96
105
42
35
17
27
21
18
29
26
Minority Interest
17
19
25
30
12
11
9
8
8
8
Other Liabilities
59
55
51
60
56
55
48
43
39
40
Total Liabilities
931
N/A
1 107
+19%
894
-19%
1 133
+27%
1 028
-9%
1 106
+8%
1 145
+4%
1 514
+32%
1 793
+18%
1 981
+10%
Equity
Common Stock
536
536
592
592
586
568
568
568
567
567
Retained Earnings
350
438
695
823
978
1 185
1 340
1 481
1 665
1 894
Additional Paid In Capital
125
168
565
565
474
340
320
272
310
326
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
46
Treasury Stock
0
0
0
0
38
0
0
98
68
47
Other Equity
534
584
234
193
82
117
85
56
77
5
Total Equity
1 544
N/A
1 726
+12%
2 087
+21%
2 174
+4%
2 082
-4%
2 210
+6%
2 313
+5%
2 279
-1%
2 551
+12%
2 791
+9%
Total Liabilities & Equity
2 475
N/A
2 833
+14%
2 982
+5%
3 308
+11%
3 110
-6%
3 316
+7%
3 458
+4%
3 793
+10%
4 344
+15%
4 772
+10%
Shares Outstanding
Common Shares Outstanding
536
536
592
592
586
568
568
554
559
563

See Also

Discover More